UAB Digital Repository of Documents 1 records found  Search took 0.00 seconds. 
1.
9 p, 204.1 KB Pseudoprogression as an adverse event of glioblastoma therapy / Balañá, Carmen (Institut Catala Oncologia (ICO)) ; Capellades, Jaume (Hospital del Mar (Barcelona, Catalunya)) ; Pineda, Estela (Hospital Clínic i Provincial de Barcelona) ; Estival, Anna (Institut Catala Oncologia (ICO)) ; Puig, Josep (Hospital Universitari de Girona Doctor Josep Trueta) ; Domenech, Sira (Institut Diagnòstic per la Imatge (IDI)) ; Verger, Eugenia (Hospital Clínic i Provincial de Barcelona) ; Pujol, Teresa (Hospital Clínic i Provincial de Barcelona) ; Martinez-García, Maria (Hospital del Mar (Barcelona, Catalunya)) ; Oleaga, Laura (Hospital Clínic i Provincial de Barcelona) ; Velarde, Josep Maria (Institut Catala Oncologia (ICO)) ; Mesia, Carlos (Hospital Universitari de Bellvitge) ; Fuentes, Rafael (Institut Catala Oncologia (ICO)) ; Marruecos, Jordi (Institut Catala Oncologia (ICO)) ; Del Barco, Sonia (Institut Catala Oncologia (ICO)) ; Villà, Salvador (Institut Catala Oncologia (ICO)) ; Carrato, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gallego Rubio, Oscar (Institut d'Investigació Biomèdica Sant Pau) ; Gil-Gil, Miguel (Hospital Universitari de Bellvitge) ; Craven-Bartle, Jordi (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Alameda, Francesc (Hospital del Mar (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona
We explored predictive factors of pseudoprogression (PsP) and its impact on prognosis in a retrospective series of uniformly treated glioblastoma patients. Patients were classified as having PsP, early progression (eP) or neither (nP). [...]
2017 - 10.1002/cam4.1242
Cancer Medicine, Vol. 6 Núm. 12 (december 2017) , p. 2858-2866  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.